Viral and non-viral risk factors for non-Hodgkin’s lymphoma in Egypt: heterogeneity by histological and immunological subtypes
- First Online:
Non-Hodgkin’s lymphomas (NHL) are etiologically heterogeneous malignancies. In Egypt, we previously reported an association of increased NHL risk with chronic hepatitis C virus (HCV) infection. Our present aim is to assess the association between HCV infection and histological subtypes of NHL.
We conducted a case–control study at the National Cancer Institute of Cairo University. Cases with NHL (n = 486) were matched to controls (n = 786) who were orthopedic patients from the same referral regions. Participants provided a blood sample for HCV markers (anti-HCV, HCV RNA) and answered a questionnaire on possible risk factors. Case–control differences were assessed by odds ratios and 95% confidence intervals from logistic regression analysis.
Cases with diffuse large B cell lymphoma (n = 146), chronic lymphocytic leukemia (n = 58), marginal zone lymphoma (n = 24), follicular lymphoma (n = 23), and mantle cell lymphoma (n = 16) were recruited. HCV RNA prevalence was 27% in controls and 26%–48% in the NHL subgroups: it was associated (p < 0.001) with diffuse large B cell, marginal zone, and follicular lymphomas with odds ratios of 3.2, 4.4, and 3.3, respectively.
HCV is a risk factor for diffuse large B cell, marginal zone, and follicular lymphomas in Egypt.
KeywordsNon-Hodgkin’s lymphoma Hepatitis C virus Egypt Epidemiology Risk factors
Hepatitis C virus
Chronic lymphocytic leukemia
World Health Organization
National Cancer Institute
Reverse transcription-polymerase chain reaction
- 1.World Health Organization (2000) Hepatitis C Infection. Report Number 164 Google Scholar
- 12.De Re V, De Vita S, Marzotto A et al (2000) Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 96:3578–3584PubMedGoogle Scholar
- 24.Hausfater P, Cacoub P, Rosenthal E et al (2000) Hepatitis C virus infection and lymphoproliferative diseases in France: a national study. The GERMIVIC Group. Am J Hematol 64:107–111. doi:10.1002/(SICI)1096-8652(200006)64:<107::AID-AJH6>3.0.CO;2-C PubMedCrossRefGoogle Scholar
- 25.Sanchez Ruiz AC, Yebra BM, Portero F, Provencio PM, Miralles FC, Espana SP (2001) Prevalence of hepatitis C virus infection in patients with non-Hodgkin’s lymphoma. Med Clin (Barc.) 116:333–334Google Scholar